Phages and HIV-1: From Display to InterplayReport as inadecuate




Phages and HIV-1: From Display to Interplay - Download this document for free, or read online. Document in PDF available to download.

1

Laboratory of Retrovirology, CRP-Sante, 84, Val Fleuri, L-1526 Luxembourg, Luxembourg

2

Service National des Maladies Infectieuses, Centre Hospitalier Luxembourg, 4, rue E. Barblé, L-1210 Luxembourg, Luxembourg





*

Author to whom correspondence should be addressed.



Abstract The complex hide-and-seek game between HIV-1 and the host immune system has impaired the development of an efficient vaccine. In addition, the high variability of the virus impedes the long-term control of viral replication by small antiviral drugs. For more than 20 years, phage display technology has been intensively used in the field of HIV-1 to explore the epitope landscape recognized by monoclonal and polyclonal HIV-1-specific antibodies, thereby providing precious data about immunodominant and neutralizing epitopes. In parallel, biopanning experiments with various combinatorial or antibody fragment libraries were conducted on viral targets as well as host receptors to identify HIV-1 inhibitors. Besides these applications, phage display technology has been applied to characterize the enzymatic specificity of the HIV-1 protease. Phage particles also represent valuable alternative carriers displaying various HIV-1 antigens to the immune system and eliciting antiviral responses. This review presents and summarizes the different studies conducted with regard to the nature of phage libraries, target display mode and biopanning procedures. View Full-Text

Keywords: phage display; HIV-1; epitope mapping; mimotopes; HIV-1 inhibitor; HIV-1 vaccine; gp120; gp41; CXCR4; CCR5 phage display; HIV-1; epitope mapping; mimotopes; HIV-1 inhibitor; HIV-1 vaccine; gp120; gp41; CXCR4; CCR5





Author: Sylvie Delhalle 1,* , Jean-Claude Schmit 1,2 and Andy Chevigné 1

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents